Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.59 GBX | +0.72% | +2.78% | +19.90% |
13/06 | EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss | AN |
13/06 | BiVictriX Therapeutics' Leukemia Treatment Shows Favorable Safety Profile | MT |
Evolution of the average Target Price on BiVictriX Therapeutics Plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- BVX Stock
- Consensus BiVictriX Therapeutics Plc